reference/25150797

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/25150797

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, N.I.H., Extramural\|Research Support, Non-U.S. Gov't
endingPage	1274
issn	1476-5586
issueIdentifier	12
pageRange	1261-1274
publicationName	Neoplasia (New York, N.Y.)
startingPage	1261
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_a500274ddff6e3ece320321eaa155c72
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_255823c85fad514e8e3168b2ad75ba2b http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_318e9d233917c440252e1a0f60575ca4 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_dcbd0e819edfe5623bf284071afca51e
bibliographicCitation	Zhao R, Ma X, Bai L, Li X, Mamouni K, Yang Y, Liu H, Danaher A, Cook N, Kucuk O, Hodges RS, Gera L, Wu D. Overcoming prostate cancer drug resistance with a novel organosilicon small molecule. Neoplasia. 2021 Dec;23(12):1261–74. PMID: 34781084; PMCID: PMC8604682.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0a618dd7b9ccf6aeb441f870cfe9c97c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4d37e1f55d5640fa9b933b8849702071 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b04b2685f685fd99d689407cdbdd4ae5 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-0105-732X http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-9050-7793 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_645bd5c7c983695f685c121707d165d3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bd5f91b483971c2320383806f58edaf6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c0407034204fef0e812732086cd31c4f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b5e11d5de60c5ef4e5e046d0091722eb http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a5b92823dcb113704ea568576c65f8cb http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_89718696b7066523167e2669fd930250 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bc387c7b5852d167296f21aa4b31ca6a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b86af13bd84cd617b597dd6be49b09eb
date	202112
identifier	https://pubmed.ncbi.nlm.nih.gov/34781084 https://pubmed.ncbi.nlm.nih.gov/PMC8604682 https://doi.org/10.1016/j.neo.2021.11.006
isPartOf	https://portal.issn.org/resource/ISSN/1476-5586 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/21648
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Overcoming prostate cancer drug resistance with a novel organosilicon small molecule
discusses	http://id.nlm.nih.gov/mesh/M0026713 http://id.nlm.nih.gov/mesh/M0001483
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D017646Q000494 http://id.nlm.nih.gov/mesh/D019008Q000187 http://id.nlm.nih.gov/mesh/D000970Q000494 http://id.nlm.nih.gov/mesh/D064129
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D004354 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D000818 http://id.nlm.nih.gov/mesh/D023041 http://id.nlm.nih.gov/mesh/D051379 http://id.nlm.nih.gov/mesh/D002460
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_c582dec943ff7b743aa0691df291cea6 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5995 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_c2b3a5ba99bc94e77229bab735b7776f http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5461123 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8983 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449

Total number of triples: 56.